These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36843124)

  • 21. From 'mental fog' to post-acute COVID-19 syndrome's executive function alteration: Implications for clinical approach.
    Pallanti S; Di Ponzio M; Gavazzi G; Gasic G; Besteher B; Heller C; Kikinis R; Makris N; Kikinis Z
    J Psychiatr Res; 2023 Nov; 167():10-15. PubMed ID: 37804756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trajectory of post-COVID brain fog, memory loss, and concentration loss in previously hospitalized COVID-19 survivors: the LONG-COVID-EXP multicenter study.
    Fernández-de-Las-Peñas C; Cancela-Cilleruelo I; Rodríguez-Jiménez J; Arias-Navalón JA; Martín-Guerrero JD; Pellicer-Valero OJ; Arendt-Nielsen L; Cigarán-Méndez M
    Front Hum Neurosci; 2023; 17():1259660. PubMed ID: 38021227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post COVID fatigue: Can we really ignore it?
    Sharma P; Bharti S; Garg I
    Indian J Tuberc; 2022 Apr; 69(2):238-241. PubMed ID: 35379408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Unusual Case of Blackout in a COVID-19 Patient: COVID-19 Brain Fog.
    Hassan L; Ahsan Z; Bint E Riaz H
    Cureus; 2023 Mar; 15(3):e36273. PubMed ID: 37073192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is brain fog?
    McWhirter L; Smyth H; Hoeritzauer I; Couturier A; Stone J; Carson AJ
    J Neurol Neurosurg Psychiatry; 2023 Apr; 94(4):321-325. PubMed ID: 36600580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
    Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
    JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain Leukocytes as the Potential Therapeutic Target for Post-COVID-19 Brain Fog.
    Kazama I
    Neurochem Res; 2023 Aug; 48(8):2345-2349. PubMed ID: 36952147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of complement immunity with brain fog in patients with long COVID.
    Hagiya H; Tokumasu K; Otsuka Y; Sunada N; Nakano Y; Honda H; Furukawa M; Otsuka F
    J Infect Chemother; 2024 Mar; 30(3):236-241. PubMed ID: 37866620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study.
    Søraas A; Kalleberg KT; Dahl JA; Søraas CL; Myklebust TÅ; Axelsen E; Lind A; Bævre-Jensen R; Jørgensen SB; Istre MS; Kjetland EF; Ursin G
    PLoS One; 2021; 16(8):e0256142. PubMed ID: 34437579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce 'Brain Fog' and Results in Behavioral Changes that Favor Viral Survival.
    Stefano GB; Ptacek R; Ptackova H; Martin A; Kream RM
    Med Sci Monit; 2021 Jan; 27():e930886. PubMed ID: 33487628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients.
    Peghin M; Palese A; Venturini M; De Martino M; Gerussi V; Graziano E; Bontempo G; Marrella F; Tommasini A; Fabris M; Curcio F; Isola M; Tascini C
    Clin Microbiol Infect; 2021 Oct; 27(10):1507-1513. PubMed ID: 34111579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic Disease Self-Management of Post-Acute Sequelae of COVID-19 Among Older Adults: A Mixed-Methods Analysis.
    Thomas-Purcell K; Davenport R; Ayala V; Purcell D; Ownby RL
    Clin Interv Aging; 2023; 18():607-617. PubMed ID: 37082741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
    Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subjective brain fog: a four-dimensional characterization in 25,796 participants.
    Alim-Marvasti A; Ciocca M; Kuleindiren N; Lin A; Selim H; Mahmud M
    Front Hum Neurosci; 2024; 18():1409250. PubMed ID: 38911226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
    Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
    JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in Clinical Presentation With Long COVID After Community and Hospital Infection and Associations With All-Cause Mortality: English Sentinel Network Database Study.
    Meza-Torres B; Delanerolle G; Okusi C; Mayor N; Anand S; Macartney J; Gatenby P; Glampson B; Chapman M; Curcin V; Mayer E; Joy M; Greenhalgh T; Delaney B; de Lusignan S
    JMIR Public Health Surveill; 2022 Aug; 8(8):e37668. PubMed ID: 35605170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
    Metyas S; Chen C; Aung T; Ballester A; Cheav S
    Curr Rheumatol Rev; 2022; 18(4):346-351. PubMed ID: 35152867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.